These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 212577)

  • 21. Induction of Epstein-Barr virus early antigen, virus capsid antigen and virus DNA synthesis by mitomycin C.
    Ernberg I; Moar MH
    J Gen Virol; 1981 Jan; 52(Pt 1):39-48. PubMed ID: 6267175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon.
    Adams A; Strander H; Cantell K
    J Gen Virol; 1975 Aug; 28(2):207-17. PubMed ID: 170370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of Epstein-Barr virus after activation of the viral genome in a "virus-negative" human lymphoblastoid cell (Raji) made resistant to 5-bromodeoxyuridine (thymidine kinase-virus antigen-immunofluorescence-herpesvirus fingerprints).
    Hampar B; Derge JG; Martos LM; Walker JL
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):78-82. PubMed ID: 4550511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.
    Luka J; Kallin B; Klein G
    Virology; 1979 Apr; 94(1):228-31. PubMed ID: 220786
    [No Abstract]   [Full Text] [Related]  

  • 25. Replication of latent Epstein-Barr virus genomes in normal and malignant lymphoid cells.
    Adams A; Pozos TC; Purvey HV
    Int J Cancer; 1989 Sep; 44(3):560-4. PubMed ID: 2550376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell cycle dependence for activation of Epstein-Barr virus by inhibitors of protein synthesis or medium deficient in arginine.
    Hampar B; Lenoir G; Nonoyama M; Derger JG; Chang S
    Virology; 1976 Feb; 69(2):660-8. PubMed ID: 176789
    [No Abstract]   [Full Text] [Related]  

  • 27. Synthesis of thymidine kinase (TK) in Epstein-Barr virus-superinfected Raji TK-negative cells.
    Roubal J; Klein G
    Intervirology; 1981; 15(1):43-8. PubMed ID: 6268568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simple assay method for susceptibility of human lymphocytes to Epstein-Barr virus infection.
    Takada K; Osato T
    Intervirology; 1982; 18(1-2):87-91. PubMed ID: 6288618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6.
    Flamand L; Stefanescu I; Ablashi DV; Menezes J
    J Virol; 1993 Nov; 67(11):6768-77. PubMed ID: 8411380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Programming of events in Epstein-Barr virus-activated cells induced by 5-iododeoxyuridine.
    Hampar B; Derge JG; Nonoyama M; Chang SY; Tagamets A; Showalter SD
    Virology; 1974 Nov; 62(1):71-89. PubMed ID: 4371498
    [No Abstract]   [Full Text] [Related]  

  • 31. Replication of latent Epstein-Barr virus genomes in Raji cells.
    Adams A
    J Virol; 1987 May; 61(5):1743-6. PubMed ID: 3033303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the transformation of human lymphocytes by Epstein-Barr virus. I. Sequential occurrence from the virus-determined nuclear antigen synthesis, to blastogenesis, to DNA synthesis.
    Takada K; Osato T
    Intervirology; 1979; 11(1):30-9. PubMed ID: 218892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
    Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
    J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Recover of transforming Epstein-Barr virus (EBV) from Raji cells superinfected with NPC-KT EBV].
    Takimoto T; Iwawaki J; Ishikawa S; Tanaka S; Masuda K
    Nihon Jibiinkoka Gakkai Kaiho; 1987 Nov; 90(11):1767-71. PubMed ID: 2833593
    [No Abstract]   [Full Text] [Related]  

  • 35. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference.
    Miller G; Robinson J; Heston L; Lipman M
    Proc Natl Acad Sci U S A; 1974 Oct; 71(10):4006-10. PubMed ID: 4372601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneity of Epstein-Barr virus derived from a nasopharyngeal carcinoma that has transforming and lytic properties.
    Sato H; Takimoto T; Ogura H; Tanaka J; Hatano M; Glaser R
    J Natl Cancer Inst; 1986 Jun; 76(6):1019-24. PubMed ID: 3012175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Neocarzinostatin on the cultured Burkitt lymphoma cells, with particular reference to the enhancement of production of Epstein-Barr virus.
    Sairenji T; Yamaguchi J; Katagiri S; Hinuma Y
    Gan; 1970 Oct; 61(5):451-60. PubMed ID: 4320553
    [No Abstract]   [Full Text] [Related]  

  • 38. Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus.
    Lin JC; Smith MC; Pagano JS
    J Virol; 1984 Apr; 50(1):50-5. PubMed ID: 6321799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perspectives on interactions of acyclovir with Epstein-Barr and other herpes viruses.
    Pagano JS; Datta AK
    Am J Med; 1982 Jul; 73(1A):18-26. PubMed ID: 6285710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infection of human B lymphocytes with high multiplicities of Epstein-Barr virus: kinetics of EBNA expression, cellular DNA synthesis, and mitosis.
    Robinson J; Smith D
    Virology; 1981 Mar; 109(2):336-43. PubMed ID: 6259815
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.